Table of Contents
Journal of Allergy
Volume 2011 (2011), Article ID 276258, 5 pages
http://dx.doi.org/10.1155/2011/276258
Review Article

X-Ray Contrast Media Mechanisms in the Release of Mast Cell Contents: Understanding These Leads to a Treatment for Allergies

UCSD Emeritus, USA

Received 14 May 2011; Revised 15 July 2011; Accepted 16 July 2011

Academic Editor: K. Blaser

Copyright © 2011 Elliott C. Lasser. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. C. Lasser, J. H. Lang, S. G. Lyon, A. E. Hamblin, and M. M. Howard, “Prekallikrein-Kallikrein conversion rate as a predictor of contrast material catastrophies,” Radiology, vol. 140, no. 1, pp. 11–15, 1981. View at Google Scholar
  2. E. C. Lasser, R. A. Simon, S. G. Lyon, A. E. Hamblin, and R. Stein, “Heparin-like anticoagulants in asthma,” Allergy, vol. 42, no. 8, pp. 619–625, 1987. View at Google Scholar · View at Scopus
  3. S. G. Lyon, E. C. Lasser, and R. Stein, “Modification of an amidolytic heparin assay to express protein-bound heparin,” Thrombosis and Haemostasis, vol. 58, no. 3, pp. 884–887, 1987. View at Google Scholar · View at Scopus
  4. R. Schweitzer-Stenner and I. Pecht, “Cutting edge: death of a dogma or enforcing the artificial: monomeric IgE binding may initiate mast cell response by inducing its receptor aggregation,” Journal of Immunology, vol. 174, no. 8, pp. 4461–4464, 2005. View at Google Scholar · View at Scopus
  5. N. Watanabe, N. Oriuchi, T. Higuchi et al., “In vitro effect of contrast agents during immunoradiometric assay for tumour-associated antigens,” Nuclear Medicine Communications, vol. 19, no. 1, pp. 63–70, 1998. View at Google Scholar · View at Scopus
  6. E. C. Lasser, “The multipotential pseudoantigenicity of x-ray contrast media: pseudoantigen excess may downregulate the release of hypotensive mediators,” International Archives of Allergy and Immunology, vol. 123, no. 4, pp. 282–290, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. E. C. Lasser and G. E. Lamkin, “Can contrast media act as “pseudoantigens”?” Academic Radiology, vol. 5, pp. S95–S106, 1998. View at Google Scholar · View at Scopus
  8. E. C. Lasser and M. S. Lamkin, “Mechanisms of blood pressure change after bolus injections of x-ray contrast media,” Academic Radiology, vol. 9, supplement 1, pp. S72–S75, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. W. Krause, H. Miklautz, U. Kollenkirchen, and G. Heimann, “Physicochemical parameters of x-ray contrast media,” Investigative Radiology, vol. 29, no. 1, pp. 72–80, 1994. View at Google Scholar · View at Scopus
  10. C. L. Cronan and F. W. Schneider, “Cooperativity and composition of the linear amylose-iodine-iodide complex,” Journal of Physical Chemistry, vol. 73, no. 11, pp. 3990–4004, 1969. View at Google Scholar · View at Scopus
  11. Carried out under the supervision of Dr. Robert Naclerio and associates at the University of Chicago Medical School, 2010 with the approval of the institutional review board.
  12. R. C. Strunk and G. R. Bloomberg, “Omalizumab for asthma,” The New England Journal of Medicine, vol. 354, no. 25, pp. 2689–2695, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. F. E. R. Simons, “Epinephrine (adrenaline) in the first-aid, out-of-hospital treatment of anaphylaxis,” Novartis Foundation Symposium, vol. 257, pp. 228–243, 2004. View at Google Scholar · View at Scopus